These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32997752)

  • 21. Blood group ABO polymorphism inhibits SARS-CoV-2 infection and affects COVID-19 progression.
    Yamamoto F; Yamamoto M; Muñiz-Diaz E
    Vox Sang; 2021 Jan; 116(1):15-17. PubMed ID: 32965025
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigating Whether Blood Type Is Linked to COVID-19 Risk.
    Rubin R
    JAMA; 2020 Oct; 324(13):1273. PubMed ID: 32936219
    [No Abstract]   [Full Text] [Related]  

  • 23. Lack of association between SNPsrs8176719 (O blood group) and COVID-19: Data from Spanish age matched patients and controls.
    Coto E; Albaiceta GM; Clemente MG; Gómez J
    Transfusion; 2021 Feb; 61(2):654-656. PubMed ID: 33191530
    [No Abstract]   [Full Text] [Related]  

  • 24. The morbidity and mortality of COVID-19 are associated with ABO and Rh blood groups.
    Ansari-Lari M; Saadat M
    Eur J Prev Cardiol; 2021 Sep; 28(11):e26-e28. PubMed ID: 34551081
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
    Gemmati D; Tisato V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between blood type and COVID-19 infection, intubation, and death.
    Zietz M; Zucker J; Tatonetti NP
    Nat Commun; 2020 Nov; 11(1):5761. PubMed ID: 33188185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABO blood groups and severe outcomes in COVID-19: A meta-analysis.
    Bhattacharjee S; Banerjee M; Pal R
    Postgrad Med J; 2022 Mar; 98(e2):e136-e137. PubMed ID: 35232874
    [No Abstract]   [Full Text] [Related]  

  • 28. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (
    Kim YC; Jeong BH
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infection and thrombosis associated with COVID-19: Possible role of the ABO blood group.
    Cai J; Zhang H; Tang M
    Med Clin (Barc); 2021 Sep; 157(5):e281. PubMed ID: 33593638
    [No Abstract]   [Full Text] [Related]  

  • 30. Questioning the association between ABO type and outcomes in patients with COVID-19.
    May JE; McGwin G; Gangaraju R; Paschal R; Weaver K; Lima JLO; Marques MB
    Ann Hematol; 2021 Dec; 100(12):3081-3082. PubMed ID: 33205336
    [No Abstract]   [Full Text] [Related]  

  • 31. Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2.
    Breiman A; Ruvën-Clouet N; Le Pendu J
    PLoS Pathog; 2020 May; 16(5):e1008556. PubMed ID: 32437478
    [No Abstract]   [Full Text] [Related]  

  • 32. Found: genes that sway the course of the coronavirus.
    Kaiser J
    Science; 2020 Oct; 370(6514):275-276. PubMed ID: 33060342
    [No Abstract]   [Full Text] [Related]  

  • 33. Audio Interview: The Challenges of Safe Reopening.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jun; 382(26):e113. PubMed ID: 32579842
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactivation of SARS-CoV-2 infection following recovery from COVID-19.
    Chen Z; Xie W; Ge Z; Wang Y; Zhao H; Wang J; Xu Y; Zhang W; Song M; Cui S; Wang X; Pan CQ
    J Infect Public Health; 2021 May; 14(5):620-627. PubMed ID: 33848891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 and Body Iron: A Survey on Phenomenological and Genetic Correlations.
    Lawaczeck R
    ACS Chem Neurosci; 2020 Dec; 11(24):3996-4000. PubMed ID: 33196159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA genotyping of the ABO gene showed a significant association of the A-group (A1/A2 variants) with severe COVID-19.
    Gómez J; Albaiceta GM; García-Clemente M; García-Gala JM; Coto E
    Eur J Intern Med; 2021 Jun; 88():129-132. PubMed ID: 33750629
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study.
    Paranjpe I; Chaudhary K; Johnson KW; Jaladanki SK; Zhao S; De Freitas JK; Pujdas E; Chaudhry F; Bottinger EP; Levin MA; Fayad ZA; Charney AW; Houldsworth J; Cordon-Cardo C; Glicksberg BS; Nadkarni GN
    PLoS One; 2021; 16(2):e0247366. PubMed ID: 33626098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection?
    Hodžić A; de la Fuente J; Cabezas-Cruz A
    ACS Infect Dis; 2020 Dec; 6(12):3104-3108. PubMed ID: 33180463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
    Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
    J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.